Enhancing cerebral vasculature analysis with pathlength-corrected 2D angiographic parametric imaging: A feasibility study.

BACKGROUND: 2D angiographic parametric imaging (API) quantitatively extracts imaging biomarkers related to contrast flow and is conventionally applied to 2D digitally subtracted angiograms (DSA's). In the interventional suite, API is typically performed using 1-2 projection views and is limited by vessel overlap, foreshortening, and depth-integration of contrast motion. PURPOSE: This work explores the use of a pathlength-correction metric to overcome the limitations of 2D-API: the primary objective was to study the effect of converting 3D contrast flow to projected contrast flow using a simulated angiographic framework created with computational fluid dynamics (CFD) simulations, thereby removing acquisition variability. METHODS: The pathlength-correction framework was applied to in-silico angiograms, generating a reference (i.e., ground-truth) volumetric contrast distribution in four patient-specific intracranial aneurysm geometries. Biplane projections of contrast flow were created from the reference volumetric contrast distributions, assuming a cone-beam geometry. A Parker-weighted reconstruction was performed to obtain a binary representation of the vessel structure in 3D. Standard ray tracing techniques were then used to track the intersection of a ray from the focal spot with each voxel of the reconstructed vessel wall to a pixel in the detector plane. The lengths of each ray through the 3D vessel lumen were then projected along each ray-path to create a pathlength-correction map, where the pixel intensity in the detector plane corresponds to the vessel width along each source-detector ray. By dividing the projection sequences with this correction map, 2D pathlength-corrected in-silico angiograms were obtained. We then performed voxel-wise (3D) API on the ground-truth contrast distribution and compared it to pixel-wise (2D) API, both with and without pathlength correction for each biplane view. The percentage difference (PD) between the resultant API biomarkers in each dataset were calculated within the aneurysm region of interest (ROI). RESULTS: Intensity-based API parameters, such as the area under the curve (AUC) and peak height (PH), exhibited notable changes in magnitude and spatial distribution following pathlength correction: these now accurately represent conservation of mass of injected contrast media within each arterial geometry and accurately reflect regions of stagnation and recirculation in each aneurysm ROI. Improved agreement was observed between these biomarkers in the pathlength-corrected biplane maps: the maximum PD within the aneurysm ROI is 3.3% with pathlength correction and 47.7% without pathlength correction. As expected, improved agreement with ROI-averaged ground-truth 3D counterparts was observed for all aneurysm geometries, particularly large aneurysms: the maximum PD for both AUC and PH was 5.8%. Temporal parameters (mean transit time, MTT, time-to-peak, TTP, time-to-arrival, TTA) remained unaffected after pathlength correction. CONCLUSIONS: This study indicates that the values of intensity-based API parameters obtained with conventional 2D-API, without pathlength correction, are highly dependent on the projection orientation, and uncorrected API should be avoided for hemodynamic analysis. The proposed metric can standardize 2D API-derived biomarkers independent of projection orientation, potentially improving the diagnostic value of all acquired 2D-DSA's. Integration of a pathlength correction map into the imaging process can allow for improved interpretation of biomarkers in 2D space, which may lead to improved diagnostic accuracy during procedures involving the cerebral vasculature.

Use of high-speed angiography HSA-derived boundary conditions and Physics Informed Neural Networks (PINNs) for comprehensive estimation of neurovascular hemodynamics.

Purpose: Physics-informed neural networks (PINNs) and computational fluid dynamics (CFD) have both demonstrated an ability to derive accurate hemodynamics if boundary conditions (BCs) are known. Unfortunately, patient-specific BCs are often unknown, and assumptions based upon previous investigations are used instead. High speed angiography (HSA) may allow extraction of these BCs due to the high temporal fidelity of the modality. We propose to investigate whether PINNs using convection and Navier-Stokes equations with BCs derived from HSA data may allow for extraction of accurate hemodynamics in the vasculature. Materials and Methods: Imaging data generated from in vitro 1000 fps HSA, as well as simulated 1000 fps angiograms generated using CFD were utilized for this study. Calculations were performed on a 3D lattice comprised of 2D projections temporally stacked over the angiographic sequence. A PINN based on an objective function comprised of the Navier-Stokes equation, the convection equation, and angiography-based BCs was used for estimation of velocity, pressure and contrast flow at every point in the lattice. Results: Imaging-based PINNs show an ability to capture such hemodynamic phenomena as vortices in aneurysms and regions of rapid transience, such as outlet vessel blood flow within a carotid artery bifurcation phantom. These networks work best with small solution spaces and high temporal resolution of the input angiographic data, meaning HSA image sequences represent an ideal medium for such solution spaces. Conclusions: The study shows the feasibility of obtaining patient-specific velocity and pressure fields using an assumption-free data driven approach based purely on governing physical equations and imaging data.

Eye-Lens Dose Reduction using Region of Interest (ROI) Attenuators in Neuroimaging.

Lens dose can be high during neuro-interventional procedures, increasing the risk of cataractogenesis. Although beam collimation can be effective in reducing lens dose, it also restricts the FOV. ROI imaging with a reduced-dose peripheral field permits full-field information with reduced lens dose. This work investigates the magnitude of lens-dose reduction possible with ROI imaging. EGSnrc Monte-Carlo calculations of lens dose were made for the Zubal head phantom as a function of gantry angulation and head shift from isocenter for both large and small FOV's. The lens dose for ROI attenuators of varying transmission was simulated as the weighted sum of the lens dose from the small ROI FOV and that from the attenuated larger FOV. Image intensity and quantum mottle differences between ROI and periphery can be equalized by image processing. The lens dose varies considerably with beam angle, head shift, and field size. For both eyes, the lens-dose reduction with an ROI attenuator increases with LAO angulation, being highest for lateral projections and lowest for PA. For an attenuator with small ROI field (5 × 5 cm) and 20% transmission, the lens dose for lateral projections is reduced by about 75% compared to a full dose 10 ×10 cm FOV, while the reduction ranges between 30 and 40% for PA projections. Use of ROI attenuators can substantially reduce the dose to the lens of the eye for all gantry angles and head shifts, while allowing peripheral information to be seen in a larger FOV.

Geometrically independent contrast dilution gradient (CDG) velocimetry using photon-counting 1000 fps High Speed Angiography (HSA) for 2D velocity distribution estimation.

Purpose: Previous studies have demonstrated the efficacy of contrast dilution gradient (CDG) analysis in determining large vessel velocity distributions from 1000 fps high-speed angiography (HSA). However, the method required vessel centerline extraction, which made it applicable only to non-tortuous geometries using a highly specific contrast injection technique. This study seeks to remove the need for a priori knowledge regarding the direction of flow and modify the vessel sampling method to make the algorithm more robust to non-linear geometries. Materials and Methods: 1000 fps HSA acquisitions were obtained in vitro with a benchtop flow loop using the XC-Actaeon (Varex Inc.) photon-counting detector, and in silico using a passive-scalar transport model within a computational fluid dynamics (CFD) simulation. CDG analyses were obtained using gridline sampling across the vessel, and subsequent 1D velocity measurement in both the x- and y-directions. The velocity magnitudes derived from the component CDG velocity vectors were aligned with CFD results via co-registration of the resulting velocity maps and compared using mean absolute percent error (MAPE) between pixels values in each method after temporal averaging of the 1-ms velocity distributions. Results: Regions well-saturated with contrast throughout the acquisition showed agreement when compared to CFD (MAPE of 18% for the carotid bifurcation inlet and MAPE of 27% for the internal carotid aneurysm), with respective completion times of 137 seconds and 5.8 seconds. Conclusions: CDG may be used to obtain velocity distributions in and surrounding vascular pathologies provided the contrast injection is sufficient to provide a gradient, and diffusion of contrast through the system is negligible.

Angiographic velocimetry analysis using contrast dilution gradient method with a 1000 frames per second photon-counting detector.

Purpose: Contrast dilution gradient (CDG) analysis is a quantitative method allowing blood velocity estimation using angiographic acquisitions. Currently, CDG is restricted to peripheral vasculature due to the suboptimal temporal resolution of current imaging systems. We investigate extension of CDG methods to the flow conditions of proximal vasculature using 1000 frames per second (fps) high-speed angiographic (HSA) imaging. Approach: We performed in-vitro HSA acquisitions using the XC-Actaeon detector and 3D-printed patient-specific phantoms. The CDG approach was used for blood velocity estimation expressed as the ratio of temporal and spatial contrast gradients. The gradients were extracted from 2D contrast intensity maps synthesized by plotting intensity profiles along the arterial centerline at each frame. In-vitro results obtained at various frame rates via temporal binning of 1000 fps data were retrospectively compared to computational fluid dynamics (CFD) velocimetry. Full-vessel velocity distributions were estimated at 1000 fps via parallel line expansion of the arterial centerline analysis. Results: Using HSA, the CDG method displayed agreement with CFD at or above 250 fps [mean-absolute error (MAE): 2.6±6.3 cm/s, p=0.05]. Relative velocity distributions correlated well with CFD at 1000 fps with universal underapproximation due to effects of pulsatile contrast injection (MAE: 4.3 cm/s). Conclusions: Using 1000 fps HSA, CDG-based extraction of velocities across large arteries is possible. The method is sensitive to noise; however, image processing techniques and a contrast injection, which adequately fills the vessel assist algorithm accuracy. The CDG method provides high resolution quantitative information for rapidly transient flow patterns observed in arterial circulation.

Application of 1,000 fps High-Speed Angiography to In-Vitro Hemodynamic Evaluation of Left Ventricular Assist Device Outflow Graft Configurations.

Left ventricular assist device (LVAD)-induced hemodynamics are characterized by fast-moving flow with large variations in velocity, making quantitative assessments difficult with existing imaging methods. This study demonstrates the ability of 1,000 fps high-speed angiography (HSA) to quantify the effect of the surgical implantation angle of a LVAD outflow graft on the hemodynamics within the ascending aorta in vitro . High-speed angiography was performed on patient-derived, three-dimensional-printed optically opaque aortic models using a nonsoluble contrast media, ethiodol, as a flow tracer. Outflow graft configuration angles of 45° and 90° with respect to the central aortic axis were considered. Projected velocity distributions were calculated from the high-speed experimental sequences using two methods: a physics-based optical flow algorithm and tracking of radio-opaque particles. Particle trajectories were also used to evaluate accumulated shear stress. Results were then compared with computational fluid dynamics (CFD) simulations to confirm the results of the high-speed imaging method. Flow patterns derived from HSA coincided with the impingement regions and recirculation zones formed in the aortic root as seen in the CFD for both graft configurations. Compared with the 45° graft, the 90° configuration resulted in 81% higher two-dimensional-projected velocities (over 100 cm/s) along the contralateral wall of the aorta. Both graft configurations suggest elevated accumulated shear stresses along individual trajectories. Compared with CFD simulations, HSA successfully characterized the fast-moving flow and hemodynamics in each LVAD graft configuration in vitro , demonstrating the potential utility of this technology as a quantitative imaging modality.

A Prototype Software System for Intra-procedural Staff Dose Monitoring and Virtual Reality Training for Fluoroscopically Guided Interventional Procedures.

Staff dose management in fluoroscopically guided interventional procedures is a continuing problem. The scattered radiation display system (SDS), which our group has developed, provides in-room visual feedback of scatter dose to staff members during fluoroscopically guided interventional (FGI) procedures as well as extra-procedure staff and resident training. There have been a number of virtual safety training systems developed that provide detailed feedback for staff, but utilize expensive graphics processing units (GPUs) and dosimeter systems, or interaction with the x-ray system in a manner which entails additional radiation exposure and is not compatible with the As Low as Reasonably Achievable paradigm. The SDS, on the other hand, incorporates a library of look-up-table (LUT) room scatter distributions determined using the EGSnrc Monte Carlo software, which facilitates accurate and rapid system update without the need for GPUs. Real-time display of these distributions is provided for feedback to staff during a procedure. After a procedure is completed, machine parameter and staff position log files are stored, retaining all of the exposure and geometric information for future review. A graphic user interface (GUI) in Unity3D enables procedure playback and interactive virtual-reality (VR) staff and resident training with virtual control of exposure conditions using an Oculus headset and controller. Improved staff and resident awareness using this system should lead to increased safety and reduced occupational dose.

2D vessel contrast dilution gradient (CDG) analysis using 1000 fps high speed angiography (HSA) for velocity distribution estimation.

Purpose: Contrast dilution gradient (CDG) analysis is a technique used to extract velocimetric 2D information from digitally subtracted angiographic (DSA) acquisitions. This information may then be used by clinicians to quantitatively assess the effects of endovascular treatment on flow conditions surrounding pathologies of interest. The method assumes negligible diffusion conditions, making 1000 fps high speed angiography (HSA), in which diffusion between 1 ms frames may be neglected, a strong candidate for velocimetric analysis using CDG. Previous studies have demonstrated the success of CDG analysis in obtaining velocimetric one-dimensional data at the arterial centerline of simple vasculature. This study seeks to resolve velocity distributions across the entire vessel using 2D-CDG analysis with HSA acquisitions. Materials and Methods: HSA acquisitions for this study were obtained in vitro with a benchtop flow loop at 1000 fps using the XC-Actaeon (Direct Conversion Inc.) photon counting detector. 2D-CDG analyses were compared with computational fluid dynamics (CFD) via automatic co-registration of the results from each velocimetry method. This comparison was performed using mean absolute error between pixel values in each method (after temporal averaging). Results: CDG velocity magnitudes were slightly under approximated relative to CFD results (mean velocity: 27 cm/s, mean absolute error: 4.3 cm/s) as a result of incomplete contrast filling. Relative 2D spatial velocity distributions in CDG analysis agreed well with CFD distributions qualitatively. Conclusions: CDG may be used to obtain velocity distributions in and surrounding vascular pathologies provided diffusion is negligible relative to convection in the flow, given a continuous gradient of contrast.

Semi-automatic Co-Registration of 3D CFD Vascular Geometry to 1000 FPS High-Speed Angiographic (HSA) Projection Images for Flow Determination Comparisons.

Image co-registration is an important tool that is commonly used to quantitatively or qualitatively compare information from images or data sets that vary in time, origin, etc. This research proposes a method for the semi-automatic co-registration of the 3D vascular geometry of an intracranial aneurysm to novel high-speed angiographic (HSA) 1000 fps projection images. Using the software Tecplot 360, 3D velocimetry data generated from computational fluid dynamics (CFD) for patient-specific vasculature models can be extracted and uploaded into Python. Dilation, translation, and angular rotation of the 3D velocimetry data can then be performed in order to co-register its geometry to corresponding 2D HSA projection images of the 3D printed vascular model. Once the 3D CFD velocimetry data is geometrically aligned, a 2D velocimetry plot can be generated and the Sørensen-Dice coefficient can be calculated in order to determine the success of the co-registration process. The co-registration process was performed ten times for two different vascular models and had an average Sørensen-Dice coefficient of 0.84 ± 0.02. The method presented in this research allows for a direct comparison between 3D CFD velocimetry data and in-vitro 2D velocimetry methods. From the 3D CFD, we can compare various flow characteristics in addition to velocimetry data with HSA-derived flow metrics. The method is robust to other vascular geometries as well.

The effect of underlying bone on the beam angular correction in calculating the skin dose of the head in neuro-interventional imaging.

Skin dose depends on the surface shape, underlying tissue, beam energy, field size, and incident beam angle. These dependencies were determined in order to apply corrections in the skin-dose-tracking system (DTS) for accurate estimation of the risk of deterministic skin effects during fluoroscopically-guided neuro-interventional procedures. The primary-plus-scatter dose was calculated averaged over the skin thickness with underlying subcutaneous fat, and various thicknesses of skull bone on the surface of a cylindrical water phantom to simulate the head. The skin dose was calculated using EGSnrc Monte-Carlo (MC) software with 2×1010 incident photons and was normalized to the incident primary dose. Simulations were done for beam incident angles from 90 to 10 degrees with the skin surface, field sizes from 5 to 15 cm, bone thicknesses of 0, 1, 5, and 9 mm, and beam energies from 60 to 120 kVp. The results show the scatter-plus-primary to incident-primary dose ratio decreases with decreasing incident angle to the skin and with increasing thickness of underlying bone, while it increases with increasing field size and with increasing beam energy. The correction factor reduces the skin dose for angled rays and the reduction can be substantial for small angles of incidence, especially for angles below 50 degrees. For neuro-interventional procedures, the skin dose-area product (SDAP) with angular and bone correction is shown to be less than that without correction. The results of this study can be used to increase the accuracy of patient-skin-dose estimation for the head during fluoroscopic procedures.

Comparison of skin dose calculated by the dose tracking system (DTS) with a beam angular correction factor and that calculated by Monte-Carlo.

Skin dose is dependent on the incident beam angle and corrections are needed for accurate estimation of the risk of deterministic effects of the skin. Angular-correction factors (ACF) were calculated and incorporated into our skin-dose-tracking system (DTS) and the results compared to Monte-Carlo simulations for a neuro-interventional procedure. To obtain the ACF's, EGSnrc Monte-Carlo (MC) software was used to calculate the dose averaged over 0.5, 1, 2, 3, 4 and 5 mm depth into the entrance surface of a water phantom at the center of the field as a function of incident beam to skin angle from 90-10 degrees for beam field sizes from 5-15 cm and for beam energies from 60-120 kVp. These values were normalized to the incident primary dose to obtain the ACF. The angle of incidence at each mesh vertex in the beam on the surface of the DTS patient graphic was calculated as the complement of the angle between the normal vector and the vector of the intersecting ray from the tube focal spot; skin dose at that vertex was calculated using the corresponding ACF. The skin-dose values with angular correction were compared to those calculated using MC with a matching voxelized phantom. The results show the ACF decreases with decreasing incident angle and skin thickness, and increases with increasing field size and kVp. Good agreement was obtained between the skin dose calculated by the angular-corrected DTS and MC, while use of the ACF allows the real-time performance of the DTS to be maintained.

Estimation of patient skin dose in fluoroscopy: summary of a joint report by AAPM TG357 and EFOMP.

BACKGROUND: Physicians use fixed C-arm fluoroscopy equipment with many interventional radiological and cardiological procedures. The associated effective dose to a patient is generally considered low risk, as the benefit-risk ratio is almost certainly highly favorable. However, X-ray-induced skin injuries may occur due to high absorbed patient skin doses from complex fluoroscopically guided interventions (FGI). Suitable action levels for patient-specific follow-up could improve the clinical practice. There is a need for a refined metric regarding follow-up of X-ray-induced patient injuries and the knowledge gap regarding skin dose-related patient information from fluoroscopy devices must be filled. The most useful metric to indicate a risk of erythema, epilation or greater skin injury that also includes actionable information is the peak skin dose, that is, the largest dose to a region of skin. MATERIALS AND METHODS: The report is based on a comprehensive review of best practices and methods to estimate peak skin dose found in the scientific literature and situates the importance of the Digital Imaging and Communication in Medicine (DICOM) standard detailing pertinent information contained in the Radiation Dose Structured Report (RDSR) and DICOM image headers for FGI devices. Furthermore, the expertise of the task group members and consultants have been used to bridge and discuss different methods and associated available DICOM information for peak skin dose estimation. RESULTS: The report contributes an extensive summary and discussion of the current state of the art in estimating peak skin dose with FGI procedures with regard to methodology and DICOM information. Improvements in skin dose estimation efforts with more refined DICOM information are suggested and discussed. CONCLUSIONS: The endeavor of skin dose estimation is greatly aided by the continuing efforts of the scientific medical physics community, the numerous technology enhancements, the dose-controlling features provided by the FGI device manufacturers, and the emergence and greater availability of the DICOM RDSR. Refined and new dosimetry systems continue to evolve and form the infrastructure for further improvements in accuracy. Dose-related content and information systems capable of handling big data are emerging for patient dose monitoring and quality assurance tools for large-scale multihospital enterprises.

A parametric fitting technique for rapid determination of a skin-dose correction factor for angle of beam incidence during image-guided endovascular procedures.

Skin dose is dependent on the incident beam angle and corrections are needed for accurate estimation of the risk of deterministic effects of the skin. To obtain the angular correction factors (ACF's), EGSnrc Monte Carlo (MC) software was used to calculate the skin dose as a function of incident x-ray beam angle at the center of the field for beam energies from 60 to 120 kVp, field sizes from 5 to 15 cm, and thicknesses of Cu beam filters from 0.2 to 0.5 mm. All MC simulations used 3×1010 incident photons. The dose was averaged over a 1 mm depth on the entrance surface of a 40×40 cm by 20 cm thick water phantom and was then normalized to the incident primary dose which was calculated using NIST mass energy absorption coefficients and by integrating over the beam energy spectrum. The Matlab tool, 'cftool', was used to fit these normalized dose values to power law equations as a function of incident beam angle, with coefficients that were fit to polynomials as a function of kVp. Separate fitting was done for different beam sizes and beam filters. The skin dose values calculated using the ACF determined from the fitted functional formulas agreed with that calculated by MC with a mean absolute percentage error (MAPE) less than 3% over the entire range of incident angles and kVp values. This fitting technique allows an ACF to be quickly determined for accurate skin dose calculation.

Assessment of Eye Lens Dose Reduction When Using Lateral Lead Shields on the Patient's Head during Neurointerventional Fluoroscopic Procedures and Cone-beam Computed Tomography (CBCT) Scans.

The purpose of this study was to evaluate the effect of placing small lead shields on the temple region of the skull to reduce radiation dose to the lens of the eye during interventional fluoroscopically-guided procedures and cone-beam computed tomography (CBCT) scans of the head. EGSnrc Monte-Carlo code was used to determine the eye lens dose reduction when using lateral lead shields for single x-ray projections, CBCT scans with different protocols, and interventional neuroradiology procedures with the Zubal computational head phantom. A clinical C-Arm system was used to take radiographic projections and CBCT scans of anthropomorphic head phantoms without and with lead patches, and the images were compared to assess the effect of the shields. For single lateral projections, a 0.1 (0.3)-mm-thick lead patch reduced the dose to the left-eye lens by 40% to 60% (55% to 80%) from 45° to 90° RAO and to the right-eye lens by around 30% (55%) from 70° to 90° RAO. For different CBCT protocols, the reduction of lens dose with a 0.3-mm-thick lead patch ranged from 20% to 53% at 110 kVp. For CBCT scans of the anthropomorphic phantom, the lead patch introduced streak artifacts that were mainly in the orbital regions but were insignificant in the brain region where most neurointerventional activity occurs. The dose to the patient's eye lens can be reduced considerably by placing small lead shields over the temple region of the head without substantially compromising image quality in neuro-imaging procedures.

Single-center experience of using high definition (Hi-Def) imaging during neurointervention treatment of intracranial aneurysms using flow diverters.

BACKGROUND: A new dual resolution imaging x-ray detector system (Canon Medical Systems Corporation, Tochigi, Japan) has a standard resolution 194 µm pixel conventional flat-panel detector (FPD) mode and a high-resolution 76 µm high-definition (Hi-Def) mode in a single unit. The Hi-Def mode enhances the visualization of the intravascular devices. OBJECTIVE: We report the clinical experience and physician evaluation of this new detector system with Hi-Def mode for the treatment of intracranial aneurysms using a Pipeline embolization device (PED). METHODS: During intervention at our institute, under large field of view (FOV) regular resolution FPD mode imaging, the catheter systems and devices were first guided to the proximity of the treatment area. Final placement and deployment of the PED was performed under Hi-Def mode guidance. A post-procedure 9-question physician survey was conducted to qualitatively assess the impact of Hi-Def mode visualization on physicians' intraoperative decision-making. One-sample t-test was performed on the responses from the survey. Dose values reported by the x-ray unit were also recorded. RESULTS: Twenty-five cases were included in our study. The survey results indicated that, for each of the nine questions, the physicians in all cases indicated that the Hi-Def mode improved visualization compared with the FPD mode. For the 25 cases, the mean cumulative entrance air kerma was 2.35 Gy, the mean dose area product (DAP) was 173.71 Gy.cm2, and the mean x-ray exposure time was 39.30 min. CONCLUSIONS: The Hi-Def mode improves visualization of flow diverters and may help in achieving more accurate placement and deployment of devices.

High-Definition Zoom Mode: A High Resolution X-ray Microscope for Neurointerventional Treatment Procedures.

BACKGROUND AND PURPOSE: Visualization of structural details of treatment devices during neurointerventional procedures can be challenging. A new true two-resolution imaging X-ray detector system features a 194 µm pixel conventional flat-panel detector (FPD) mode and a 76 µm pixel high-resolution high-definition (Hi-Def) zoom mode in one detector panel. The Hi-Def zoom mode was developed for use in interventional procedures requiring superior image quality over a small field of view (FOV). We report successful use of this imaging system during intracranial aneurysm treatment in 1 patient with a Pipeline-embolization device and 1 patient with a low-profile visualized intramural support (LVIS Blue) device plus adjunctive coiling. METHODS: A guide catheter was advanced from the femoral artery insertion site to the proximity of each lesion using standard FPD mode. Under magnified small FOV Hi-Def imaging mode, an intermediate catheter and microcatheters were guided to the treatment site, and the PED and LVIS Blue plus coils were deployed. Radiation doses were tracked intraprocedurally. RESULTS: Critical details, including structural changes in the PED and LVIS Blue and position and movement of the microcatheter tip within the coil mass, were more readily apparent in Hi-Def mode. Skin-dose mapping indicated that Hi-Def mode limited radiation exposure to the smaller FOV of the treatment area. CONCLUSIONS: Visualization of device structures was much improved in the high-resolution Hi-Def mode, leading to easier, more controlled deployment of stents and coils than conventional FPD mode.

Developing a database of 3-D scattered radiation distributions for a c-arm fluoroscope as a function of exposure parameters and phantom.

The purpose of this work is to develop a database of 3D scattered radiation dose-rate distributions to estimate the staff dose by location around a C-Arm fluoroscopic system in an interventional procedure room. The primary x-ray beam of a Toshiba Infinix fluoroscopy machine was modeled using EGSnrc Monte Carlo code and the scattered radiation distributions were calculated using 5 × 109 photons per simulation. These 3D distributions were determined over the volume of the room as a function of various parameters such as the beam kVp and beam filter, the size and shape of the field, the angulation of the C-arm, and the phantom size and shape. Two phantom shapes were used in this study: cylindrical and super-ellipses. The results show that shape of the phantom will affect the dose-rate distribution at distances less than 100 cm, with a higher intensity for the super-ellipse. The scatter intensity per entrance air kerma is seen to be approximately proportional to field area and to increase with increasing kVp. The scatter changes proportionally with increases in primary entrance air kerma for factors such as pulse rate, mA and pulse width. This database will allow estimation of the scatter distribution in the procedure room and, when displayed to the staff during a procedure, may facilitate a reduction of occupational dose.

Calculation of Forward Scatter Dose Distribution at the skin entrance from the patient table for fluoroscopically guided interventions using a pencil beam convolution kernel.

The forward-scatter dose distribution generated by the patient table during fluoroscopic interventions and its contribution to the skin dose is studied. The forward-scatter dose distribution to skin generated by a water table-equivalent phantom and the patient table are calculated using EGSnrc Monte-Carlo and Gafchromic film as a function of x-ray field size and beam penetrability. Forward scatter point spread function's (PSFn) were generated with EGSnrc from a 1×1 mm simulated primary pencil beam incident on the water model and patient table. The forward-scatter point spread function normalized to the primary is convolved over the primary-dose distribution to generate scatter-dose distributions. The utility of PSFn to calculate the entrance skin dose distribution using DTS (dose tracking system) software is investigated. The forward-scatter distribution calculations were performed for 2.32 mm, 3.10 mm, 3.84 mm and 4.24 mm Al HVL x-ray beams for 5×5 cm, 9×9 cm, 13.5×13.5 cm sized x-ray fields for water and 3.1 mm Al HVL x-ray beam for 16.5×16.5 cm field for the patient table. The skin dose is determined with DTS by convolution of the scatter dose PSFn's and with Gafchromic film under PMMA "patient-simulating" blocks for uniform and for shaped x-ray fields. The normalized forward-scatter distribution determined using the convolution method for water table-equivalent phantom agreed with that calculated for the full field using EGSnrc within ±6%. The normalized forward-scatter dose distribution calculated for the patient table for a 16.5×16.5 cm FOV, agreed with that determined using film within ±2.4%. For the homogenous PMMA phantom, the skin dose using DTS was calculated within ±2 % of that measured with the film for both uniform and non-uniform x-ray fields. The convolution method provides improved accuracy over using a single forward-scatter value over the entire field and is a faster alternative to performing full-field Monte-Carlo calculations.

Investigation of organ dose variation with adult head size and pediatric age for neuro-interventional projections.

The purpose of this study was to evaluate the effect of patient head size on radiation dose to radiosensitive organs, such as the eye lens, brain and spinal cord in fluoroscopically guided neuro-interventional procedures and CBCT scans of the head. The Toshiba Infinix C-Arm System was modeled in BEAMnrc/EGSnrc Monte-Carlo code and patient organ and effective doses were calculated in DOSxynrc/EGSnrc for CBCT and interventional procedures. X-ray projections from different angles, CBCT scans, and neuro-interventional procedures were simulated on a computational head phantom for the range of head sizes in the adult population and for different pediatric ages. The difference of left-eye lens dose between the mean head size and the mean ± 1 standard deviation (SD) ranges from 20% to 300% for projection angles of 0° to 90° RAO. The differences for other organs do not vary as much and is only about 10% for the brain. For a LCI-High CBCT protocol, the difference between mean and mean ± 1 SD head size is about 100% for lens dose and only 10% for mean and peak brain dose; the difference between 20 and 3 year-old mean head size is an increase of about 200% for the eye lens dose and only 30% for mean and peak brain dose. Dose for all organs increases with decreasing head size for the same reference point air kerma. These results will allow size-specific dose estimates to be made using software such as our dose tracking system (DTS).